Top Markets
Coin of the day
Impact BioMedical Inc. Impact BioMedical Inc.

Impact BioMedical Inc.

IBO
Ранг среди акций #25450
Houston, Texas-based Impact BioMedical Inc., founded in 2018, focuses on... Houston, Texas-based Impact BioMedical Inc., founded in 2018, focuses on discovering and developing innovative products and therapeutic options for both specialty biopharmaceuticals and consumer healthcare markets. The company features several key technologies: its "Linebacker" platform utilizes small molecule electrophilically enhanced polyphenol compounds with potential applications in treating cancer, inflammatory diseases, and neurological conditions. Additionally, "Laetose" technology, a unique blend of sugar and inositol, is designed to counteract the inflammatory and metabolic responses usually triggered by sugar consumption. Impact BioMedical also creates "functional fragrance formulations," which are a series of fragrances incorporating specialized botanical ingredients for antimicrobial purposes, or as active additives in items like insect repellents, cleaning products, personal care items, and fabrics. Rounding out its offerings is the "Equivir/Equivir G" technology, a distinctive mix of polyphenols that has exhibited antiviral properties, suitable for use in health supplements and medications.
Цена акции
$0.4587
Последняя синхронизация: 2026-08-20
Рыночная капитализация
$49.46M
Изменение (1 день)
5.89%
Изменение (1 год)
-22.83%
Страна
US
Торговля Impact BioMedical Inc. (IBO)

Категория

Коэффициент P/B для Impact BioMedical Inc. (IBO)
Коэффициент P/B на 2026 TTM: 0
Согласно последним финансовым отчетам и цене акций Impact BioMedical Inc., текущий коэффициент P/B (TTM) составляет 0. В конце 2026 он составлял 0.
История P/B для Impact BioMedical Inc. с 2026 по 2026
Коэффициент P/B в конце каждого года
Год P/B Изменить
Недостаточно данных для указанных дат.
Коэффициент P/B для аналогичных компаний или конкурентов
Компания P/B Разница P/B Страна
6.3419 -
US
6.2413 -
NL
2.5054 -
AU
- -
CH
3.7087 -
US